This secondary analysis of 3 randomized clinical trials evaluates the safety and efficacy of tralokinumab in older patients with moderate-to-severe atopic dermatitis.
All Keywords
Communicable Diseases Research
감염병 연구데이터
This secondary analysis of 3 randomized clinical trials evaluates the safety and efficacy of tralokinumab in older patients with moderate-to-severe atopic dermatitis.